Erythromycin 4% topical gel formulation:
CHDR1752-B
Unknown small_molecule completed
Quick answer
Erythromycin 4% topical gel formulation: for Inflammation; Skin is a Unknown program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Inflammation; Skin
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed